Research Institute
Filter News
Found 2,352 articles
-
Berkeley Lights to Report Fourth Quarter and Full Year 2022 Financial Results on February 23, 2023
2/13/2023
Berkeley Lights, Inc., a life sciences tools company, announced that the Company will be reporting financial results for the fourth quarter and full year 2022 after market on Thursday, February 23, 2023.
-
Carestream Collaborates with Robarts Research Institute To Advance Translational Cardiothoracic and Pulmonary Disease Research
2/7/2023
Carestream Health is partnering with Robarts Research Institute to increase and demonstrate the clinical value of digital X-ray, digital tomosynthesis and dual energy technologies to help improve the outcomes of patients with cardiothoracic and pulmonary diseases.
-
KEMRI and NEC Announce Trials on Biometric-based Vaccination Management System for Newborn Children in Kenya
2/7/2023
The Kenya Medical Research Institute, NEC Corporation and Nagasaki University have developed a digital biometric-based vaccination management system for newborn children in Kenya.
-
Braxia Scientific Announces Offering up to $1.5 Million, Braxia Management to Participate in Concurrent Private Placement
2/7/2023
Braxia Scientific Corp. (CSE: BRAX) (OTC: BRAXF) (FSE: 4960) ("Braxia", or the "Company"), a medical research company providing psychiatric, innovative ketamine and psilocybin treatments for mental health disorders
-
Primary Progressive MS Is Confirmed To Be Distinct From Other MS Subtypes
2/6/2023
The Tisch MS Research Center of New York, the world’s largest independent research center focused on multiple sclerosis, has published groundbreaking new research classifying primary progressive multiple sclerosis as pathophysiologically distinct from other forms of MS.
-
Feinstein Institutes researcher discovers potential therapeutic target for lethal sepsis
2/3/2023
Sepsis is a silent and mysterious killer that makes up nearly a quarter of deaths worldwide.
-
Florida Cancer Specialists & Research Institute Appoints Hitesh Patel, MD to Executive Board
2/1/2023
Florida Cancer Specialists & Research Institute, LLC is pleased to announce that Hitesh Patel, MD has joined its Executive Board, effective January 27, 2023.
-
City of Hope to Rebrand Cancer Treatment Centers of America Locations to Reflect Transition to National System
2/1/2023
City of Hope, one of the largest cancer research and treatment organizations in the United States, announced that its subsidiary, Cancer Treatment Centers of America®, will fully transition its clinical locations to City of Hope's brand.
-
SRI International Appoints Kathlynn Brown to Biosciences Division President
1/31/2023
SRI International, an independent nonprofit research institute behind countless cutting-edge technological advances, announced the promotion of Kathlynn Brown to President of its Biosciences Division.
-
Pavankumar Tandra, MD Joins Florida Cancer Specialists & Research Institute in Sarasota
1/30/2023
Florida Cancer Specialists & Research Institute, LLC welcomes Board-certified hematologist and medical oncologist Pavankumar Tandra, MD to the statewide practice.
-
James A. Reeves, Jr., MD, Clinical Research Leader, to Retire From Florida Cancer Specialists & Research Institute
1/30/2023
Florida Cancer Specialists & Research Institute, LLC announces that James A. Reeves Jr, MD will retire from its Research Division, effective January 31, 2023.
-
RETRANSMISSION: Irwin Naturals Signs Letter of Intent to Acquire Braxia Scientific
1/30/2023
Strategic transaction assembles an experienced management and scientific team world-renowned in mental health treatment, research and development
-
Six long COVID subtypes identified at The Jackson Laboratory
1/27/2023
Over the past three years, it has become clear that, for many people, the effects of SARS-CoV-2 infection persist long after an initial case of COVID-19 wanes.
-
The Diabetes Research Institute Appoints World-Renowned Diabetes Expert, Matthias von Herrath, M.D., to Scientific Director
1/26/2023
The Diabetes Research Institute, a world leader focused on finding a cure for type 1 diabetes, recently announced the appointment of its new scientific director, Matthias von Herrath, M.D.
-
Sanford Burnham Prebys Receives Landmark Gift from T. Denny Sanford to Recruit the Top Minds in Biomedical Research
1/24/2023
Sanford Burnham Prebys announced plans to recruit up to 20 new faculty positions in research areas including cancer, neurodegeneration and computational biology.
-
Nautilus Biotechnology Partners with the Translational Genomics Research Institute (TGen) to Investigate Applications of Single-Molecule Proteomic Analysis in Diffuse Intrinsic Pontine Glioma (DIPG)
1/19/2023
Nautilus Biotechnology, Inc., a company pioneering a single-molecule protein analysis platform, and the Translational Genomics Research Institute, part of City of Hope, announced a partnership to explore the utility of the Nautilus platform by studying specific protein targets in diffuse intrinsic pontine glioma, a rare and often fatal childhood cancer.
-
Milestone Study Exploring the Significant Impact of ED Drugs on Men’s Cardiac Health Published in the Journal of Sexual Medicine
1/17/2023
A comprehensive research study manuscript examining the impact of erectile dysfunction drugs on major adverse cardiovascular events and mortality has been published by scientists from Huntington Medical Research Institutes in Pasadena, HealthCore Inc. and the University of California San Francisco.
-
Florida Cancer Specialists & Research Institute Re-Appoints Lucio Gordan, MD as President & Managing Physician of Statewide Practice
1/16/2023
Florida Cancer Specialists & Research Institute, LLC announced that Lucio Gordan, MD has assumed the role of President & Managing Physician, effective January 16, 2023.
-
Feinstein Institutes, Northwell Use Ultrasound to Treat Brain Tumors in Novel Clinical Trial
1/12/2023
Looking to harness the potential of non-invasive ultrasound technology, clinicians at Northwell Health and clinical trial investigators at The Feinstein Institutes for Medical Research have begun to participate in the Alpheus™ Medical, Inc phase 1 clinical trial and enrolled its first set of patients at North Shore University Hospital (NSUH).
-
Baylor Scott & White Research Institute, TGen and OncoHost Announce New Research Study to Analyze Resistance Mechanisms in Lung Cancer
1/10/2023
Baylor Scott & White Research Institute, the research arm of Baylor Scott & White Health; the Translational Genomics Research Institute, part of City of Hope, a nonprofit biomedical research center; and OncoHost, a global leader in next-generation precision oncology for improved personalized cancer therapy, announced a new research study.